Abstract
Background: Multiple sclerosis (MS) is considered as an inflammatory demyelinating disease with a 3-fold risk in females of child-bearing age that imposes deleterious pregnancy-related concerns for patients. We aimed to clarify the correlation of anti-Mullerian hormone (AMH) level with clinical and gynecological characteristics of RRMS patients. Methods: Fifty consecutive RRMS female patients and 50 age-matched healthy controls from among the hospital staff were enrolled in the study. The serum AMH levels of all subjects were evaluated by ELISA. T-tests and Mann-Whitney tests were used for the quantitative variables. Pearson’s chi-squared test and Fisher’s exact test were used for qualifying variables. Regression analysis was performed for AMH values. Results: The mean ± SD AMH level for the case group was 3.12 ± 3.6 and for the control group was 3.65 ± 2.06. Regression analysis detected a significant difference in AMH values between the case and control groups (p = 0.034). There were no significant influence for disease activity and therapy on AMH level in the patients. Age was the only demographic factor that predicted the AMH values in both groups (p = 0.001). Conclusion: The results showed that serum AMH values were significantly lower in MS patients; however, this finding does not necessarily have an effect on fertility.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
